Royal Biologics launched MAGNUS, a viable cellular bone allograft. MAGNUS employs viable spine-derived cells collected from a donor’s vertebral body that are preserved with a next-generation DMSO-free cryoprotectant.
Industry standard DMSO penetrates and dehydrates the cell from within to prevent crystal formation. At room temperature, DMSO-based cryoprotectants raise concerns about cytotoxicity and negative effects on cell differentiation.
In a recently-published peer-reviewed study of 75 consecutive cases at one-year follow-up, minimally invasive transforaminal lumbar interbody fusion with MAGNUS Viable Allograft demonstrated a 96% fusion rate of the 75 patients with a total of 85 levels achieving fusion at 12 months.
Royal Biologics launched MAGNUS, a viable cellular bone allograft. MAGNUS employs viable spine-derived cells collected from a donor's vertebral body that are preserved with a next-generation DMSO-free cryoprotectant.
Industry standard DMSO penetrates and dehydrates the cell from within to prevent crystal formation. At room temperature,...
Royal Biologics launched MAGNUS, a viable cellular bone allograft. MAGNUS employs viable spine-derived cells collected from a donor’s vertebral body that are preserved with a next-generation DMSO-free cryoprotectant.
Industry standard DMSO penetrates and dehydrates the cell from within to prevent crystal formation. At room temperature, DMSO-based cryoprotectants raise concerns about cytotoxicity and negative effects on cell differentiation.
In a recently-published peer-reviewed study of 75 consecutive cases at one-year follow-up, minimally invasive transforaminal lumbar interbody fusion with MAGNUS Viable Allograft demonstrated a 96% fusion rate of the 75 patients with a total of 85 levels achieving fusion at 12 months.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
